…support proof-of-principle experiments before I begin raising a pre-seed round.

- Several of the scientists I respect the most said they’d like me to develop the rejuvenation technology in their labs before spinning out a therapeutics company.

- More than 50 scientists across academia, biotech..

The ARDD Meeting (agingpharma.org) always offers novel perspectives, bringing together insights from physics, computational models, regenerative medicine, and beyond. This year, I presented my “customized cellular damage export” idea, sparking interest: An investor offered a larger donation to…

Thanks to the organizers for bringing together these interdisciplinary and quantitative perspectives: Dr. Max Unfried & Sara Hägg (moderators), Alex Zhavoronkov @elonverse.bsky.social, Daniela Bakula, and Morten Scheibye-Knudsen

#ARDD_meeting2025

agingpharma.org

Replacement is one of the essential aging interventions to substantially extend healthspan and lifespan:‬

‪https://lnkd.in/dsMVcChd

…to counteract stochasticity and considerably alter aging rates.

This is why I aim to develop customizable rejuvenation therapeutics that remove hundreds of types of damage out of cells through synthetic export.

The Aging Research & Drug Discovery Meeting (agingpharma.org) featured full-day workshops on Physics in Aging, Emerging Science & Tech, and Replacement in Aging.

More teams are now theorizing, modeling & engineering synthetic approaches to prevent/remove damage. Simulations showed this is crucial…